Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity

[1]  I. Christensen,et al.  Flow cytometric DNA ploidy defines patients with poor prognosis in node‐negative breast cancer , 2007, International journal of cancer.

[2]  G. Palestro,et al.  Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection. , 1998, American journal of clinical oncology.

[3]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  Thomas J. Smith,et al.  1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Dalla Palma,et al.  Cytometric DNA Analysis and Prognostic Biomarkers in Breast Carcinoma. Expression of P53 Product in the Different Ploidy Classes , 1997, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[6]  P. Diest,et al.  Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material: Correlations between flow cytometric, clinical, and pathologic variables , 1996 .

[7]  M. Province,et al.  S‐phase fraction and nuclear size in long term prognosis of patients with breast cancer , 1994, Cancer.

[8]  Teri Oldaker,et al.  DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients , 1993, Breast Cancer Research and Treatment.

[9]  D. Hedley,et al.  Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast , 1993, Breast Cancer Research and Treatment.

[10]  S. Fosså,et al.  Flow cytometric DNA analysis as prognostic factor in human breast carcinoma. , 1993, Pathology, research and practice.

[11]  W. McGuire,et al.  How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer , 1993, Cancer.

[12]  G. Del Bino,et al.  Prognostic significance of proliferative activity and ploidy in node-negative breast cancers. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  O. Stål,et al.  Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients. , 1992, British Journal of Cancer.

[14]  O. Stål,et al.  Relationships of DNA ploidy, S‐phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening , 1992, International journal of cancer.

[15]  Å. Borg,et al.  Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas , 1991, Breast Cancer Research and Treatment.

[16]  D. Page.  Prognosis and Breast Cancer: Recognition of Lethal and Favorable Prognostic Types , 1991, The American journal of surgical pathology.

[17]  M. Fernö,et al.  Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. , 1990, British Journal of Cancer.

[18]  G. Auer,et al.  Efficacy of combined image and flow cytometric DNA assessments in human breast cancer: a methodological study based on a routine histopathological material of 2024 excised tumour specimens. , 1990, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[19]  M. Fernö,et al.  Indicators of prognosis in node-negative breast cancer. , 1990, The New England journal of medicine.

[20]  G. Bonadonna,et al.  Systemic therapy in resectable breast cancer. , 1989, Hematology/oncology clinics of North America.

[21]  L. Case,et al.  The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer , 1989, Cancer.

[22]  K. Christov,et al.  DNA aneuploidy and cell proliferation in breast tumors , 1989, Cancer.

[23]  G. Del Bino,et al.  DNA ploidy of human breast cancer. , 1989, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[24]  K. Pritchard.  Systemic adjuvant therapy for node-negative breast cancer: proven or premature? , 1989, Annals of internal medicine.

[25]  G M Clark,et al.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.

[26]  L. Skoog,et al.  Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. , 1989, European journal of cancer & clinical oncology.

[27]  G M Clark,et al.  Steroid receptors and other prognostic factors in primary breast cancer. , 1988, Seminars in oncology.

[28]  J. Stewart.  Safety and tolerance of trimetrexate: results of a phase II multicenter study in patients with metastatic cancer refractory to conventional therapy or for which no conventional therapy exists. , 1988, Seminars in oncology.

[29]  W. McGuire,et al.  DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens , 1988, Cancer.

[30]  F. Spyratos,et al.  Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions. , 1987, Analytical and quantitative cytology and histology.

[31]  L. Skoog,et al.  A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer , 1986, Breast Cancer Research and Treatment.

[32]  Robert W. McDivitt,et al.  A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers , 1986, Cancer.

[33]  D. Horsfall,et al.  Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. , 1986, British Journal of Cancer.

[34]  Remolar Jm,et al.  [Malignant tumors of the breast]. , 1962, Prensa medica argentina.

[35]  Audenino Rg.  [Malignant tumors of the breast]. , 1960, El Dia medico.

[36]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[37]  O. N. Meland,et al.  Carcinoma of the breast. , 1948, Annals of western medicine and surgery.

[38]  B. Dutrillaux,et al.  Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis , 2005, Breast Cancer Research and Treatment.

[39]  G. Clark,et al.  S-phase fraction and breast cancer — a decade of experience , 1998 .

[40]  H. Frierson.  Grade and flow cytometric analysis of ploidy for infiltrating ductal carcinomas. , 1993, Human pathology.

[41]  K. Rogers,et al.  The identification of informative parameters in the flow cytometric analysis of breast carcinoma. , 1993, European journal of cancer.

[42]  Brian H. Mayall,et al.  Guidelines for implementation of clinical DNA cytometry , 1993 .

[43]  M. Fernö,et al.  Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. , 1992, Acta oncologica.

[44]  O. Stål,et al.  Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group. , 1992, Acta oncologica.

[45]  M. Fernö,et al.  Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. , 1992, Cytometry.

[46]  G. Feichter.  Flow cytometry of breast cancer. , 1991, Zentralblatt fur Pathologie.

[47]  D. Visscher,et al.  Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[48]  G. Bertrand,et al.  Place de l'analyse d'ADN par cytométrie en flux dans l'évaluation du pronostic des cancers du sein , 1990 .

[49]  I. Christensen,et al.  DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease. , 1988, Acta oncologica.

[50]  L. Skoog,et al.  Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma. , 1986, Breast cancer research and treatment.

[51]  H. Poulsen,et al.  Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content. , 1984, Acta radiologica. Oncology.